Why is Amerise BioScie falling/rising?

As of 27-Oct, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.65, which reflects a rise of 0.04 or 6.56%. The stock has shown strong performance recently, with a consecutive gain over the last three days and an impressive return of 18.18% over the past week. However, despite this short-term success, the stock has underperformed significantly on a year-to-date basis, down 46.28%, and over the last three years, it has declined by 38.68%. Additionally, while the stock is currently outperforming its sector by 6.28%, there has been a notable decrease in investor participation, with delivery volume dropping by 54.98% compared to the five-day average.
Broader Market Context: In comparison to the benchmark Sensex, which has gained 0.49% over the past week, Amerise Biosciences Ltd's short-term performance is considerably stronger. The stock's recent gains contrast sharply with its long-term performance, where it has lagged behind the benchmark significantly over one year and three years. The broader market has shown positive returns, with the Sensex up 8.50% year-to-date and 41.87% over three years, highlighting the challenges faced by Amerise Biosciences Ltd in maintaining investor confidence despite its recent price increase.